Bristol-Myers Squibb Co. Stock Prediction
AI-powered sentiment analysis and prediction trends for BMY, updated each market day.
BMY AI Sentiment
AI predicts Bristol-Myers Squibb Co. stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Bristol-Myers Squibb Co.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Sector
Exchange
Market Cap
$128,364,188,983
Cap Tier
Employees
32,500
Headquarters
PRINCETON, NJ
Listed Since
June 23, 1952
Website
BMY Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
BMY Volatility
Bristol-Myers Squibb Co. has shown low price volatility over the last 5 trading days. Low volatility suggests steady price action with smaller daily moves.
